 |
 |
Clinical Trial Name - PROSTACOX : Metastatic Prostate Chemotherapy
| Original Study ID : 2003/052 HP |
| NCT ID : NCT00213694 |
| Brief Title : PROSTACOX : Metastatic Prostate Chemotherapy |
| Official Title : Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer |
| Brief Summary : Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib. |
| Source : University Hospital, Rouen |
| Detailed Description : Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation |
| Overall Status : Completed |
| Start Date : November 2003 |
| End Date : June 2006 |
| Completion Date : June 2006 |
| Official Title : Phase 2 |
| Phase : Observational |
| Study Design : Screening, Longitudinal, Defined Population, Prospective Study |
| Enrollment : 52 |
| Verification Date : September 2006 |
| First Received Date : September 13, 2005 |
| Trial Eligibility |
| Criteria : Inclusion Criteria: - metastatic prostate cancer - ASCO progression criteria Exclusion Criteria: - other prostate chemotherapy |
| Gender : Male |
| Minimum Age : N/A |
| Maximum Age : N/A |
| Healthy Volunteers : No |
| Facilities |
| Facility Name : Charles Nicolle, University Hospital |
| City : ROUEN |
| Zip Code : 76031 |
| Country : France |
| Interventions |
| Type : Drug |
| Name : docetaxel and celecoxib |
Search For Specialist
Types of Treatments
| Search Trials By |
| Research |
| Most Popular Trials |
| Library |
| Discuss |